SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
75.80
Ask:
77.20
Spread: 1.40 (1.847%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Interim Management Statement

10 Aug 2011 07:01

RNS Number : 0814M
Accsys Technologies PLC
10 August 2011
 



 

 

AIM: AXS

NYSE Euronext Amsterdam: AXS

10 August 2011

 

ACCSYS TECHNOLOGIES PLC

("Accsys" or the "Company")

 

Interim Management Statement

 

·; Agreement to supply proprietary acetylated material to Medite for the production of Tricoya®, significantly accelerating the introduction of Tricoya® to the market;

·; New patents granted, further protecting the process of producing Accoya® wood;

·; Revenue from Accoya® increased by 12% (excluding sales to Diamond Wood) compared to the same quarter last year;

·; Positive 4% gross manufacturing margin achieved in first quarter;

·; Reduction in other operating costs by 16% compared to same period in previous year;

·; Working capital control improved - cash of €26.6m at 30 June 2011 compared to €27.6m at 31 March 2011

 

In the first quarter, Accsys continued to deliver on its strategy of seeding the market with Accoya®, maintaining a focus on tight cost control and continuing to explore licensing opportunities.

 

We are also pleased to announce an agreement to supply acetylated material to Medite Europe Limited ("Medite") for the production of Medite Tricoya® panels, the world's first ultra-high performance, class 1 durability medium density fibre board ("MDF") to be made using Accsys's proprietary acetylation technology.

 

Supply agreement with Medite Europe accelerates Medite Tricoya® market entry

Under the terms of the agreement, over the next 17 months Accsys Technologies expects to supply Medite with up to 7,500m3 of acetylated material, produced under the Company's patented acetylation processes at its plant in Arnhem, The Netherlands. This speciality acetylated material will be transferred to Medite's panel production facility in Clonmel, Ireland where it will be processed to produce Medite Tricoya®. First shipments of Medite Tricoya® are expected to reach the market within this financial year.

 

This agreement represents the next stage in the relationship between Accsys and Medite arising from the Joint Development Agreement ("JDA") and greatly accelerates the entry of Medite Tricoya® into the market. Medite Tricoya® will be distributed and sold by Medite, for the purposes of final market testing and market seeding, to underpin a move to commercial scale production under the licence terms set out in the JDA.

 

The agreement moves Accsys significantly closer to realising the full licence terms within the JDA, while also demonstrating a new model for the production of Tricoya® for seeding purposes and providing sales of the acetylated material from the Arnhem plant.

 

At the same time, the JDA has been amended to provide that, amongst other things, Medite be granted exclusive rights to manufacture, market, sell and distribute Medite Tricoya® in the Netherlands in addition to the United Kingdom and the Republic of Ireland. This reflects the importance of the Dutch market and is the result of the progressive market research carried out by the parties over recent months.

 

Commenting on the agreement Paul Clegg, CEO of Accsys, said,

"This agreement represents a significant strengthening of the relationship between our two companies and is an important milestone in the on-going development of Tricoya®. By supplying acetylated material to Medite for processing we have been able to bring Tricoya® to the market two years earlier than had been expected."

 

Cost control and cash management

In the first quarter, continuing focus on operational activities has resulted in a 16% reduction in other operating costs compared to the same period in the previous year. Process improvements are continuing and, together with price increases, there has been a further improvement in gross manufacturing margin from negative 2% to positive 4% compared to the same period last year.

A cash balance of €26.6m at 30 June 2011 compared to €27.6m at 31 March 2011 demonstrates a significant improvement in control over working capital compared to last year together with reduced costs and improved margins.

Agreements for the sale and leaseback of part of our land and buildings in Arnhem were entered into earlier this month. Under these agreements, we expect to realise a total of approximately €4m in two tranches. The first tranche of €2.2m has already been received and the second is due within 18 months. Under the terms of the sale leaseback, the buyer has committed to build new storage facilities, which will also allow for an improvement in wood handling logistics, being the first steps in our intended expansion of the Arnhem facility.

 

Licensing update

In January 2011, we entered into an option agreement with a major multinational corporation for a licence to build an Accoya® production plant in Europe together with the rights to manufacture and sell Accoya® in a number of European countries. Detailed due diligence and contract negotiations have been continuing since the option agreement was renewed in March and we continue to make positive progress towards what will hopefully be a full licence agreement.

We previously reported that Diamond Wood was, together with its bankers, in an advanced stage of preparing for an Initial Public Offering on the junior market of the Malaysian Stock exchange. We understand Diamond Wood continues to make progress in this respect, however this is still subject to regulatory review and formal due diligence also needs to be completed.

 

Expanding distribution network and ongoing brand development

We continue to successfully seed the market with Accoya®, paving the way for our licensing activities. Whilst month on month sales have been variable, as they have been in the wider timber industry which continues to face challenging economic conditions, Accoya® revenues (excluding sales to Diamond Wood) increased by 12% compared to the same quarter in the previous year.

We have continued to expand our Accoya® distribution network with three new distribution and supply agreements signed during the period. The first of these provides for the supply of Accoya® into the Netherlands for garden and civil construction projects, and the other two extend our reach in the United States. We have continued to develop the Accoya® global brand and are increasingly committed to providing support to new and existing distributors. We launched an online 'Sales & Marketing Toolkit' for distributors which provides easy access to marketing collateral, product and test information and training materials. We also developed an "Accoya® Website" template which has been rolled out to 17 distributors around the world, helping market Accoya® in a clear and consistent manner.

We have commenced an aggressive targeted multimedia campaign to educate the key architectural and specification audiences about the features and benefits of Accoya across many western European countries.

Accsys recently launched the revitalised and improved www.accoya.com and www.accsysplc.com websites, bringing them together in one clear and easily navigable site. The existing Accoya® website received 90,000 visitors in the last year and the new site will make it easier for visitors to find both corporate and brand information and to view Accoya projects.

Media coverage increased over the last 12 months with Accoya® featured in 299 articles in the UK and Europe and 102 articles in the USA. Accoya ® will be exhibiting at a number of trade shows in the next 6 months such as Timber Expo in the UK, Dubo Nationale in Holland, Greenbuild in USA and Batimat in France.

 

Strengthening intellectual property protection and sustainability certifications

Accsys has significantly strengthened its intellectual property portfolio having successfully been granted an additional patent protecting the process under which Accoya® wood is now produced. Patents have been granted in the United Kingdom and South Africa, with grants in other territories expected to follow. The patent, which provides Accsys with a monopoly right over the current process to produce Accoya®, is expected to further enhance the Company's licensing credentials and ability to robustly defend itself against potential competitors. Accsys now has a portfolio of three different patent families protecting its acetylation process, comprising 21 granted patents and 30 patent applications pending in various global territories.

 

Accoya® had its Cradle to Cradle Gold certification reviewed and renewed for another year and remains the only wood product to have received this level of sustainability certification. The certification provides a means to tangibly and credibly measure achievement in environmentally-intelligent design and helps customers purchase and specify products that are pursuing a broader definition of quality. This includes using environmentally safe and healthy materials such as Accoya®.

 

Employee share plan aligns employee and Company interests

We were pleased that following the introduction of an Employee Share Participation Plan in June 2011, approximately 25% of Accsys employees participated in the first round of subscription, subscribing for a total of 783,283 new ordinary shares in the Company. The Plan isintended to promote the long term growth and profitability of Accsys by providing employees with an opportunity to acquire an ownership interest in shares in the Company as an additional benefit of employment. The Board hopes this will further incentivise employees to contribute to and participate in the success of Accsys.

 

Ends

 

For further information, please contact:

 

Accsys Technologies PLC

Paul Clegg, CEO

Hans Pauli, CFO

via Citigate Dewe Rogerson

Matrix Corporate Capital LLP

 

Stephen Mischler

Nick Stone

Edmund Glover

+44 20 3206 7000

 

 

Numis Securities Limited

Christopher Wilkinson

Ben Stoop

+44 20 7260 1347

+44 20 7260 1410

Citigate Dewe Rogerson

Ginny Pulbrook

Malcolm Robertson

Suzanne Bakker

+44 20 7282 2945

+44 20 7282 2867

+31 20 575 4023

 

 

Notes to editors:

Accsys Technologies PLC (www.accsysplc.com) is an environmental science and technology company whose primary focus is on the production of Accoya® wood and technology licensing via its 100% owned subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands, a European office in London and an Americas office in Dallas, Texas. Accsys Technologies' operations comprise three principal business units: (i) the Accoya® wood production facility located in Arnhem, The Netherlands; (ii) technology development, focused on a programme of continuous improvements to the process engineering and operating protocols for the acetylation of wood which are currently under development and the development of technology for the acetylation of wood fibre; and (iii) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe. Accsys Technologies is the trading name of each of the companies within the Accsys Technologies PLC group.

Accoya® Wood (www.accoya.com) is produced by using a proprietary, non-toxic process that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood" via acetylation. Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of dimensional stability, increased coatings life, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. Leading applications include external doors and windows, shutters/shading, siding and cladding, decking, outdoor furniture/equipment and glulam beams for structural use. 

Tricoya® Wood Elements (www.tricoya.com) is Accsys Technologies' proprietary technology for the acetylation of wood fibres, chips, and particles for use in the fabrication of wood based composites, including panel products. These composites demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications which were once limited to solid wood or man-made products. Tricoya® Wood Elements is lauded as the first major innovation in the wood composites industry in more than 30 years.

Wood Acetylation is a process, which increases the amount of 'acetyl' molecules in wood, thereby changing its physical properties. The environmentally responsible process protects wood from rot by making it "inedible" to most micro-organisms and insects, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance. Acetylated wood's increased durability offers major carbon sequestration advantages, compared to other woods and man-made building materials such as steel, vinyl, and plastic.

Wood Composites include a range of derivative wood products which are manufactured by binding together the strands, particles, fibres, or veneers of wood together with adhesives to form composite materials. These products are engineered to precise design specifications which are tested to meet national or international standards.

 

Accsys Technologies is the trading name of Titan Wood Limited. ACCOYA®, TRICOYA® and the Trimarque Device are registered trademarks owned by Titan Wood Limited and may not be used or reproduced without written permission.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKMGMRKGLGMZG
Date   Source Headline
8th Jun 202610:10 amRNS-RNotice of Results & Investor Presentation via IMC
21st Apr 20267:00 amRNSTrading Update
17th Apr 20267:00 amRNSAnalyst Site Visit, Arnhem, NL
7th Apr 202611:40 amRNSStandard form for notification of major holdings
30th Mar 20267:00 amRNSChange of external auditor
30th Jan 20261:30 pmRNSTotal Voting Rights
26th Jan 20267:00 amRNSStandard form for notification of major holdings
22nd Jan 20262:00 pmRNSStandard form for notification of major holdings
16th Jan 20267:00 amRNSAccsys Employee Share Plan - Issue of Shares
11th Dec 20252:00 pmRNSStandard form for notification of major holdings
11th Dec 20257:00 amRNS-RProgressive Research Initiation Note Publication
9th Dec 20254:06 pmRNSSecondary Sale in Accsys Technologies PLC Shares
25th Nov 20257:01 amRNS-RLaunch of Accsys Sustainability Plan
25th Nov 20257:00 amRNSInterim results for six months ended 30 Sep 2025
10th Nov 20257:00 amRNSNotice of Interim Results & Investor Presentation
22nd Oct 20257:00 amRNSSuccessful Completion of Debt Refinancing
24th Sep 20255:15 pmRNSResult of AGM
24th Sep 20257:00 amRNSTrading Update
21st Jul 202510:00 amRNS2025 Annual Report and Notice of AGM
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
30th Jun 202512:30 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSPreliminary results for the year end 31 March 2025
5th Jun 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
7th May 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSAppointment of Nominated Advisor and Broker
27th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
30th Jan 20257:00 amRNSInvestor Strategy Day
29th Nov 20249:00 amRNSDirector/PDMR Shareholding
27th Nov 20243:00 pmRNSDirector LTIP Award
26th Nov 20247:00 amRNSInterim results for six months ended 30 Sep 2024
6th Nov 20242:00 pmRNSNotice of Results
25th Sep 20243:00 pmRNSResult of AGM
24th Sep 20247:00 amRNSDirectorate Update
19th Sep 20247:00 amRNSHull Plant
4th Sep 20243:15 pmRNSDirector/PDMR Shareholding
4th Sep 20247:00 amRNSTrading Update
2nd Sep 20245:00 pmRNSBlock listing 6 monthly return
2nd Sep 20245:00 pmRNSTotal Voting Rights
16th Aug 20242:00 pmRNSNotice of Annual General Meeting 2024
19th Jul 20244:30 pmRNSAnnual Financial Report
19th Jul 20244:20 pmRNSDirector/PDMR Shareholding
5th Jul 20247:00 amRNSDirectorate Update
26th Jun 20247:00 amRNSPRELIMINARY RESULTS FOR THE YEAR END 31 MARCH 2024
16th May 20247:00 amRNSDirectorate Change
2nd May 20247:00 amRNSTrading Update
28th Mar 202412:00 pmRNSDirector Interests
1st Mar 20247:00 amRNSBlock listing Six Monthly return
27th Feb 20247:00 amRNSBlock listing application to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.